FDA Warns Public About Post-Surgery Infusions

Law360, New York (November 13, 2009, 4:43 PM EST) -- The U.S. Food and Drug Administration has warned health care professionals about the risk of chondrolysis in patients who were given continuous intra-articular infusions of local anesthetics with elastomeric infusion devices to control post-surgical pain.

Because of the adverse events, the FDA said Friday that it was requiring drug manufacturers to update their product labels to warn health care professionals about the potentially serious side effect. The FDA also will require the manufacturers of pumps that may be used to infuse local anesthetics, including elastomeric infusion...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.